An interventional study of Single trocar cholecystectomy and Standard laparoscopic cholecystectomy in Cholelithiasis, sponsored by Hadassah Medical Organization. Completed at 1 site in Israel. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2020-07-30.
Sponsored by Hadassah Medical Organization · Not applicable, Interventional, and Treatment
The purpose of this study is to determine the advantages of single trocar cholecystectomy over standard laparoscopic cholecystectomy.
286 studies on the registry are indexed under Cholelithiasis; 48 are open to participants now.
This study's enrollment of 50 is below the median of 90 across 197 interventional studies indexed under Cholelithiasis.
Browse Cholelithiasis studies →Hadassah Medical Organization is the lead sponsor of 659 studies on the registry; 54 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Patients will undergo cholecystectomy by the single trocar approach
Procedure: Single trocar cholecystectomy
Standard lap choly
Procedure: Standard laparoscopic cholecystectomy
Patients with symptomatic cholelithiasis will be operated using the single trocar surgery approach
Patients with symptomatic cholelithiasis will undergo a standard laparoscopic cholecystectomy
To assess the safety and efficacy of a novel approach to minimally invasive surgery techniques.
Time frame: Continuous
To assess pain associated with the single trocar approach
Time frame: Continuous
To assess scar formation associated with single trocar approach
Time frame: Continuous
This study is completed, as verified in Apr 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Hadassah Medical Organization